breast tumors
We speculate that high levels of COX-2 induce drug resistance in ERalpha-positive breast tumors, thus reducing the survival rate of patients with such tumors.
We speculate that high levels of <span class="gene" id="16127422-2-33-38">COX-2</span> induce drug resistance in ERalpha-positive <span class="disease" id="16127422-2-82-95">breast tumors</span>, thus reducing the survival rate of patients with such tumors.